For citations:

Karateev A.E., Novikova D.S., Nasonov E.L. NEW DATA ON THE SAFETY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: THE CONCEPT OF THE HIGH CLASS-SPECIFIC CARDIOVASCULAR RISK OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS IS OUTDATED. Rheumatology Science and Practice. 2017;55(2):218-223. (In Russ.) https://doi.org/10.14412/1995-4484-2017-218-223